Metformin use in the adolescent with PCOS - An invited editorial from the Pediatric Endocrinology Perspective

Journal of Pediatric and Adolescent Gynecology

Volumn 16, Issue 2, 2003, Pages 109-111

  Dean, Heather ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b CHILDREN S HOSPITAL RESEARCH INSTITUTE OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

METFORMIN;

ADOLESCENT; CONFERENCE PAPER; DRUG EFFICACY; DRUG SAFETY; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL;

EID: 0037883233     PISSN: 10833188     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1083-3188(03)00007-X     Document Type: Conference Paper

References (16)

1. Mulchahey KM: In support of metformin use in adolescent polycystic ovary syndrome. J Pediatr Adolesc Gynecol 2002; 15:109
2. Trent M: Metformin in adolescents with polycystic ovary syndrome: opposed. J Pediatr Adolesc Gynecol 2002; 15:109
3. Norman R, Flight I: Insulin-sensitizing drugs for polycystic ovary syndrome. (Cochrane Review). In: The Cochrane Library, Issue 3. Update Software: Oxford, 2001
4. Glueck CJ, Wang P, Fontaine R, Tracy T, Sieve-Smith L: Metformin to restore normal menses in oligo-amenorrheic teenage girls with polycystic ovary syndrome (PCOS). J Adolesc Health 2001; 29:160
5. Ibanez L, Valls C, Ferrer A, Marcos MV, Rodriguez-Hierro F, de Zegher F: Sensitization to insulin induces ovulation in nonobese adolescents with anovulatory hyperandrogenism. J Clin Endocrinol Metab 2001; 86:3595
6. Arslanian SA, Lewy V, Danadian K, Saad R: Metformin therapy in obese adolescents with polycystic ovary syndrome and impaired glucose intolerance: amelioration of exaggerated adrenal response to adrenocorticotropin with reduction of insulinemia/insulin resistance. J Clin Endocrinol Metab 2002; 87:1555
7. Freemark M, Bursey D: The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes. Pediatrics 2001; 107:E55
8. Kay JP, Alemzadeh R, Langley G, D'Angelo L, Smith P, Holshouser S: Beneficial effects of metformin in normoglycemic morbidly obese adolescents. Metabolism 2001; 50:1457
9. Jones KL, Arslanian S, Peterokova VA, Park J-S, Tomlinson MJ: Effect of metformin in pediatric patients with type 2 diabetes: a randomized controlled trial. Diabetes Care 2002; 25:89
10. Dean HJ: Treatment of type 2 diabetes in children. A plea for randomized controlled trials. Paed Child Health 1999; 4:265
11. Knowler WC, Barrett-Connor E, Fowler SSE, et al: Diabetes Prevention Programme Research Group: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346:393
12. Clinical Investigation of Medicinal Products in the Pediatric Population. ICH Harmonized Tripartite Guideline. Available: http://www.ich.org/pdfICH/e11step4.pdf (accessed July 7, 2002)
13. Dean HJ, Sellers EAC: Steatohepatitis in children with type 2 diabetes mellitus. Diabetes 2001; 50:A378
14. Tuomilehto J, Lindstrom J, Eriksson JG, et al: Finnish Diabetes Prevention Study Group: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344:1343
15. Campbell K, Waters E, O'Meara S, Kelly S, Summerbell C: Interventions for preventing obesity in children. (Cochrane Review). In: The Cochrane Library, Issue 4. Update Software: Oxford, 2002
16. Harvey EL, Glenny A-M, Kirk SFL, Summerbell CD: Improving health professionals' management and the organization of care for overweight and obese people. (Cochrane Review). In: The Cochrane Library, Issue 4. Update Software: Oxford, 2002